| Irene Schneider, | |
|
108a Glenwood Road #223, Glenwood Landing, NY 11547 | |
| (516) 671-4659 | |
| Not Available |
| Full Name | Irene Schneider |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 108a Glenwood Road #223, Glenwood Landing, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033485982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 010081-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Irene Schneider, 108a Glenwood Road #223, Glenwood Landing, NY 11547 Ph: (516) 671-4659 | Irene Schneider, 108a Glenwood Road #223, Glenwood Landing, NY 11547 Ph: (516) 671-4659 |
News Archive
In an examination of leukemic stem cells (LSC), researchers have found that patients with acute myeloid leukemia who had higher activity of certain LSC genes had worse overall, event-free and relapse-free survival, according to a study in the December 22/29 issue of JAMA.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it received FDA Fast Track designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients suffer from the progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
HIV/AIDS advocates and scientists, including a U.S. Nobel laureate, on Tuesday in a letter to South African President Thabo Mbeki called for Health Minister Manto Tshabalala-Msimang to step down and protested the government's response to the HIV/AIDS epidemic, the Wall Street Journal reports.
Building upon previous work, researchers at the Icahn School of Medicine at Mount Sinai identified cells in the embryos of mice that are precursors to blood stem cells or hematopoietic stem/progenitor cells.
MTG Biotherapeutics, an immuno-oncology company developing novel therapeutics for the treatment of cancer, today announced that the US Food and Drug Administration has granted Orphan Drug Designation for MTG-201, an advanced biologic therapy targeting Dickkopf-3 gene defects in various cancers, for the treatment of malignant mesothelioma.
› Verified 9 days ago
Ms. Victoria Ann Schuppe, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 136 Glenwood Rd., Glenwood Landing, NY 11547 Phone: 516-676-1445 Fax: 516-676-1449 | |
Ms. Mary Theresa Quinn, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 136 Glenwood Rd, Glenwood Landing, NY 11547 Phone: 516-676-1445 Fax: 516-676-1449 | |
Nardine N Salama, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 108 Scudders Ln, Glenwood Landing, NY 11547 Phone: 551-221-1290 | |
Ms. Suzanne Marie Casey, MS PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10 Maple St., Glenwood Landing, NY 11547 Phone: 516-526-9214 Fax: 516-759-2115 | |
Certified Physical Therapy Assoiciates, Pc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 136 Glenwood Rd., Glenwood Landing, NY 11547 Phone: 516-676-1445 Fax: 516-676-1449 |